secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2024-07-25T23:59:59+00:00
Accession:  0001104659-24-082637
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Armata formalizes CMO Pastagia's salary at $456,800; improves severance to 12 months
--------------------------------------------------------------------------------

- Dr. Pastagia's base salary confirmed at $456,800 (effective Jan 1, 2023).
- Target bonus increased to 50% of salary for FY2024; no 2023 bonus awarded.
- Eligible for annual equity grants starting 2025; current intent ~$300,000 fair value.
- Severance extended from 6 to 12 months base salary for involuntary termination without cause.
- Amendment also updates title to Chief Medical Officer (serving since Jan 1, 2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465924082637/0001104659-24-082637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465924082637/tm2420145d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-082637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer